The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

EFRACEA 40 mg modified-release hard capsules

Galderma InternationalPA22743/006/001

Main Information

Trade NameEFRACEA 40 mg modified-release hard capsules
Active SubstancesDoxycycline
Dosage FormModified-release capsule, hard
Licence HolderGalderma International
Licence NumberPA22743/006/001

Group Information

ATC CodeJ01AA02 doxycycline


License statusAuthorised
Licence Issued30/01/2009
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back